Nirmatrelvir-ritonavir for the treatment of COVID-19 patients: A systematic review and meta-analysis.

Cheema, Huzaifa A; Jafar, Uzair; Sohail, Aruba; Shahid, Abia; Sahra, Syeda; Ehsan, Muhammad; Athar, Farwa; Shah, Jaffer; Sah, Ranjit

Cheema, Huzaifa A; Jafar, Uzair; Sohail, Aruba; Shahid, Abia; Sahra, Syeda; Ehsan, Muhammad; Athar, Farwa; Shah, Jaffer; Sah, Ranjit.

Afiliación

Cheema HA; Division of Infectious Diseases, Department of Medicine, King Edward Medical University, Lahore, Pakistan.
Jafar U; Division of Infectious Diseases, Department of Medicine, King Edward Medical University, Lahore, Pakistan.
Sohail A; Department of Medicine, Dow University of Health Sciences, Karachi, Pakistan.
Shahid A; Division of Infectious Diseases, Department of Medicine, King Edward Medical University, Lahore, Pakistan.
Sahra S; Department of Infectious Diseases, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.
Ehsan M; Division of Infectious Diseases, Department of Medicine, King Edward Medical University, Lahore, Pakistan.
Athar F; Division of Infectious Diseases, Department of Medicine, King Edward Medical University, Lahore, Pakistan.
Shah J; New York State Department of Health, Albany, New York, USA.
Sah R; Tribhuvan University Teaching Hospital, Institute of Medicine, Kathmandu, Nepal.

J Med Virol ; 95(2): e28471, 2023 02.

Article en En | MEDLINE | ID: mdl-36606609

Asunto(s)

COVID-19; Ritonavir; Humanos; Clasificación; Tratamiento Farmacológico de COVID-19

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Ritonavir / COVID-19 Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies / Systematic_reviews Límite: Humans Idioma: En Revista: J Med Virol Año: 2023 Tipo del documento: Article País de afiliación: Pakistán

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google